The latest closing stock price for Alnylam Pharmaceuticals as of November 07, 2024 is 272.22.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $37,889 today, roughly 38 times their original investment - a 20.09% compound annual growth rate over 20 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 11.8% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.97, which is 47.8% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 202.50.
An investor who bought $1,000 worth of Alnylam Pharmaceuticals stock at the IPO in 2004 would have $37,889 today, roughly 38 times their original investment - a 20.09% compound annual growth rate over 20 years.
The all-time high Alnylam Pharmaceuticals stock closing price was 300.55 on October 16, 2024.
The Alnylam Pharmaceuticals 52-week high stock price is 304.39, which is 11.8% above the current share price.
The Alnylam Pharmaceuticals 52-week low stock price is 141.97, which is 47.8% below the current share price.
The average Alnylam Pharmaceuticals stock price for the last 52 weeks is 202.50.